InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: Biostockclub post# 155790

Wednesday, 07/04/2018 7:59:13 PM

Wednesday, July 04, 2018 7:59:13 PM

Post# of 461142
Bio:

Thank you. Your posts are insightful, and it is apparent from reading them that you are highly intelligent and knowledgeable. I value reading what you publish.

On your point about inflexibility, it reminds me about the resistance that has existed throughout history to new scientific theories. Reasons for explaining this resistance are many such as distaste for change, religious views, politics, etc. Additionally, there is this standard of ”peer review” that I see as an obstacle to new scientific theories, especially for treating Alzheimer’s. Who would you consider to be in the ”peer” group that reviews and approves a new scientific theory that Anavex is pursuing? What are these ”peers” thinking about this new theory to treat Alzheimer’s and other CNS diseases? What are the reasons these ”peers” may be dismissive or resistant to AVXL 2-73 or any other drug based on a completely new theory that clashes with the conventional big pharma view?

Here we have tiny Anavex pursuing innovative treatments for diseases -- some in the blockbuster category like Alzheimer’s and Parkinson's. Tiny companies are not supposed to do this! How dare Anavex step on the toes of giant pharmaceutical companies!





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News